Open buy · week 7
Novavax jumps 21.9% to a fresh 90-week high, and the weekly close confirms it
Our view last week
Novavax printed a fresh 30-day high in the 11.1 area this week, but the close did not confirm it: the stock slips 1.6% and ends near the week's low. A week ago price was climbing unopposed, now it has met its first obstacle. The structure holds, with a rising ADX and 5 higher lows on the daily chart. Novavax stock keeps its place among the weekly buy signals on US stocks, up 17% since entry: swing trading with wide swings.
This week's summary
Novavax closes the week with a 21.9% jump and a fresh 90-week high, this time confirmed by the weekly close: a week ago the new high failed to hold into the close, now it has. The ADX has been rising for 6 weeks and money flow stays positive. Novavax stock keeps its place among the weekly buy signals on healthcare stocks, up more than 42% since entry: a swing trading setup with a wide move and elevated volatility.
IQS Phase
60
ordinary
Signal Strength
87
high · wide & volatile
Sizing
FULL
Ranking
#3 / 92
US stocks in progress
Trade P&L %
+42.62%
from signal to date, no stop loss
Novavax (NVAX) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 3rd among the 92 Longs already running for US stocks in our ranking, with a signal strength of 87 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +2.79% · monthly +2.54%
NVAX belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content